Rzeszowskie Centrum Chorób Serca i Naczyń Spółka z Ograniczoną Odpowiedzialnością (KRS 0000351371, NIP 8133615176) is a Polish company, headquartered in Rzeszów, Podkarpackie voivodeship. RZESZOWSKIE CENTRUM CHORÓB SERCA I NACZYŃ operates in: Hospital activities (PKD 86.10.Z). Industry: Healthcare. The company has been listed in the National Court Register since March 17, 2010.
Historical suspension of activities
Suspension: July 17, 2017 - resumed: July 18, 2019
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Rzeszowskie Centrum Chorób Serca i Naczyń
Identity
- Name
- Rzeszowskie Centrum Chorób Serca i Naczyń Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- March 17, 2010
- Registry status as of
- April 19, 2026
- Latest entry
- April 19, 2026
- Founding act
- 15.10.2009 R., NOTARIUSZ BEATA CZAPOR, KANCELARIA NOTARIALNA UL. MICKIEWICZA 19, 35-064 RZESZÓW, REP.A NR 4724/2009 12.0…
Articles of association history (2)
- October 15, 2009: 15.10.2009 R., NOTARIUSZ BEATA CZAPOR, KANCELARIA NOTARIALNA UL. MICKIEWICZA 19, 35-064 RZESZÓW, REP.A NR 4724/2009 12.02.2010 R., NOTARIUSZ BEATA CZAPOR, KANCELARIA NOTARIALNA UL. MICKIEWICZA 19, 35-064 RZESZÓW, REP.A NR 490/2010 - ZMIANA PAR.1 UST.2 UMOWY SPÓŁKI
- September 12, 2011: DATA SPORZĄDZENIA AKTU: 9.12.2011 R. NUMER REPERTORIUM: REPERTORIUM A NUMER 2995/2011 NOTARIUSZ: BOGUSŁAW KOBISZ KANCELARIA NOTARIALNA BOGUSŁAW KOBISZ, UL. PODPROMIE 8A, 35-051 RZESZÓW NUMERY ZMIENIONYCH, DODANYCH, USUNIĘTYCH PARAGRAFÓW: ZMIENIONO: § 2 PKT.1 PPKT 1
Activities
Main activity
86.10.ZHospital activities
Other activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- PODPROMIE, 8A, 35-051, RZESZÓW, POLSKA
- Voivodeship
- PODKARPACKIE
- District
- M. RZESZÓW
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- AE:PL-38998-98150-HTCHH-26
Risk and payment profile - Rzeszowskie Centrum Chorób Serca i Naczyń
Credibility rating
55.9 / 100
Average credibility
Insolvency risk
Very low
Low threat
Closure risk
6
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
0
0/16 yrs
Board changes
0
0/16 yrs
PKD changes
1
1/16 yrs
Name changes
0
0/16 yrs
Data from 16 years of registry activity.
Credibility history
Payment reliability score from 2018–2023
Current: C (56/100)
Trend: improving (+2.2 pts/year)
Moderate payment credibility - the company is able to meet its obligations, but some indicators warrant caution.
Trade credit limit history
Standard limit from 2018–2023
Current: 0 PLN
Safe: 0 PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Rzeszowskie Centrum Chorób Serca i Naczyń
Founded
March 17, 2010
16 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
RZESZÓW
PODKARPACKIE
Primary PKD
86.10.Z
Hospital activities
Share capital
6.0 K PLN
30 shares total
Shareholders
3
shareholders
Board
1 person
Filed years
3 years
2018–2023 · profitable: 0/3
Registry entries
36
latest: April 19, 2026
Revenue
N/A
2023
Net profit
N/A
2023
Assets
808.7 K PLN
2023
Equity
563.6 K PLN
2023
Valuation
539.5 K PLN
Low confidence
Low confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Rzeszowskie Centrum Chorób Serca i Naczyń.
No ratings
Related articles
News
Longevity Center launches Longevity Academy: Poland's first accredited longevity-medicine educational programme for doctors
Warsaw-based Longevity Center sp. z o.o. (KRS 0000796083, ul. Belwederska 9) has launched Longevity Academy - one of the first in the world and the first in Poland accredited longevity-medicine educational programme for doctors. Accreditation by the Polish Medical Chamber; scientific partner: the Buck Institute for Research on Aging in California. The programme is built on 6+ years of clinical practice and 3,000+ patients.
Explainer
Voxel in 2026: a Kraków operator of medical-imaging centres and radiopharmaceuticals, an mWIG40 issuer with a two-member management board
Voxel S.A. (KRS 0000238176), headquartered at ul. Wielicka 265 in Kraków, is a Polish operator of medical-imaging centre networks (MRI, CT, X-ray, ultrasound, mammography) and a radiopharmaceutical producer. The company was founded in 2005, listed on the WSE since 2011. It operates under the Voxel-Diagnostic brand at several dozen locations across Poland. A two-member management board, a five-member supervisory board.
